While not a vaccine, it represents the next best option for HIV prevention. After the prestigious journal Science recognized Lenacapavir as 2024’s “Breakthrough of the Year,” Gilead ...

Nearly a quarter of people living with HIV in the U.S. are women, and the number is only growing. The highest number of new ...

The Trump administration has terminated funding for HIV, malaria and maternal health programs it had labeled lifesaving.

A revolutionary advancement in HIV prevention technology stands at a critical crossroads as recent policy decisions threaten ...

Several protesters were arrested Wednesday after U.S. Agency for International Development workers were told via a text ...

The UNODC Country Office in Iran has been at the forefront of introducing and implementing drug and HIV prevention, treatment ...

Working with a contract drug manufacturing and testing firm in Britain, 25 to 30 healthy volunteers are starting to receive ...

David Furnish’s leadership at EJAF proves brands can do more than raise awareness —they can dismantle stigma and drive ...

The programme has lived up to its promise. The investment of over US$110 billion since being launched has been transformative ...

| Dr. Buzón discusses bridging science and reality, highlighting the vital role of real-world evidence in advancing HIV care ...

By Elvis Basudde Kyeyune President Donald Trump’s recent executive or- der suspending all activities of the United States ...